Discontinued Tests
Test | Code | Comment |
---|---|---|
Alpha Fetoprotein on Amniotic fluid | AFPA | Effective 03/11/23 |
Arabinose | ARBN | Effective 23/04/23 |
Calreticulin – CALR exon 9 variant screen | CALR | 16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel) |
Cartilage Antibody | ACA | Effective 23/04/23 |
Collagen Type 1 Cross-Linked N-Telopeptide – NTX | NTX | Effective 17/11/23 |
Collagen (Type I, II, IV) Antibodies | COAB | Test no longer available. Effective 01/03/24 |
Coxsackie IgM or Enterovirus IgM | COXM | Effective 26/05/23 |
Endometrial Immune Profiling Biopsy RNA | 23RF | Effective 01/02/24. An alternative test Decidualization Score (DS) is available from the same sample type: test code DSRF, TAT 2-3 weeks. |
Functional Vitamin B Profile (B1, B2, B6) | BIOF | Effective 23/04/23 |
Glutathione – Red Cell | GLUR | Effective 23/04/23 |
Glutathione Reductase | GRED | Effective 23/04/23 |
Gut Permeability Profile (With PEG 400) (Leaky Gut Test) | GPP | Effective 23/04/23 |
Hair Mineral Analysis | HMA | Effective 23/04/23 |
Hepcidin | HPDN | Effective 17/05/23 |
Human Anti-Mouse Ab’s (To Confirm Presence Of Heterophilic Ab’s) | HAMA | Effective 23/04/23 |
Inner Ear Antigen | IEA | Temporarily suspended until further notice. 27/10/23 |
JAK2 – exon 12 sequencing (rare variants) | JE12 | 16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel) |
JAK2 V617F genotyping assay | JAK2 | 16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel) |
KRAS/NRAS screening assay | MGP | 12/7/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel) |
Kryptopyrroles | KRYP | Effective 23/04/23 |
LDL7 Subfractions
| LDL7 | Temporarily discontinued until further notice. Contact TDL Referrals Department for an update. Effective 16/02/24 |
Listeria Antibodies | LIST | Effective 26/05/23 |
Lutein | LUTE | Effective 23/04/23 |
Lycopene | LYCO | Effective 23/04/23 |
Mannose Binding Lectin | MBL | Effective 11/05/23 |
Melanin (Urine) | MELA | Effective 23/04/23 |
MPL exon 10 analysis | MPL | 16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel) |
Niacin – Blood | NIAC | Effective 23/04/23 |
NMP22 (Bladder Cancer Marker) | NMP | Replaced by UBC – Urinary Bladder cancer antigen 23/04/23 |
Noonan Syndrome Prenatal Screen – PTPN11 exons 3 & 11 | GENE | Effective 03/11/23 |
Novadiage Stool Parasite | NOVA | Temporarily suspended until further notice. 17/04/2024. |
NPM1 mutascreen assay | NPM | 16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel) |
Pethidine – Urine | UPET | Effective 23/04/23 |
Poliovirus (Serotypes 1-3) Antibodies By Neutralization | POLO | Effective 17/05/23 |
Small Intestinal Bacterial Overgrowth Test | SIBO | Effective 23/04/23 |
T-SPOT®.COVID | TCEL | Effective 04/12/23 |
Vitamin D2/D3 | D2D3 | Effective 23/04/23 |
Ziwig Endotest | ENDT | Temporarily suspended until further notice. 27/10/23 |